Education
About Us
Working with TipRanks
Follow Us
Milestone Scientific (MLSS)
:MLSS
MLSS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.54 - $1.39
Previous CloseN/A
Volume1.27M
Average Volume (3M)93.83K
Market Cap
$71.66M
Enterprise Value$68.35M
Total Cash (Recent Filing)$743.43K
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.79
Next Earnings
Apr 07, 2025EPS Estimate
-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding77,892,080
10 Day Avg. Volume77,397
30 Day Avg. Volume93,826
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)8.86
Price to Cash Flow (P/CF)-20.20
P/FCF Ratio0.00
Enterprise Value/Market Cap0.95
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.06
Enterprise Value/Ebitda-10.38
Forecast
1Y Price Target
$3.00Price Target Upside226.09% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
---
Milestone Scientific News
PremiumCompany Announcements
Milestone Scientific Delays Yearly Report Filing
PremiumCompany Announcements
Milestone Scientific Director Resigns Amid Personal Reasons
PremiumCompany Announcements
Milestone Scientific Inc. Reports Q3 2024 Financials---
Bulls Say, Bears Say
Bulls Say
Earnings PotentialThe Medicare price assignment marks a significant milestone for the company, and should enable broader access and adoption of the technology within the pain management community.
Financial StabilityAs of June 30, 2024, MLSS had cash and equivalents of $5.8M and no debt, with an expected average cash burn of $0.1M per quarter through 2025, indicating financial stability.
Strategic PartnershipsThe strategic partnership with Axial Biologics is off to a strong start, generating roughly 40 high-quality leads and a robust pipeline of pain clinics in trials across multiple states.
Bears Say
Earnings PerformanceRevenue was slightly below consensus, and the GAAP loss per share was slightly wider than expected.
Market Expansion ChallengesMLSS is advancing discussions with four additional JMAC regions to expand coverage beyond the initial three, which is viewed as a step towards receiving broad reimbursement.
---
Ownership Overview
22.99% Insiders
3.88% Mutual Funds
0.90% Other Institutional Investors
69.49% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
MLSS FAQ
What was Milestone Scientific’s price range in the past 12 months?
Milestone Scientific lowest stock price was $0.54 and its highest was $1.39 in the past 12 months.
What is Milestone Scientific’s market cap?
Milestone Scientific’s market cap is $71.66M.
When is Milestone Scientific’s upcoming earnings report date?
Milestone Scientific’s upcoming earnings report date is Apr 07, 2025 which is in 2 days.
How were Milestone Scientific’s earnings last quarter?
Milestone Scientific released its earnings results on Nov 14, 2024. The company reported -$0.02 earnings per share for the quarter, missing the consensus estimate of -$0.01 by -$0.01.
Is Milestone Scientific overvalued?
According to Wall Street analysts Milestone Scientific’s price is currently Undervalued.
Does Milestone Scientific pay dividends?
Milestone Scientific does not currently pay dividends.
What is Milestone Scientific’s EPS estimate?
Milestone Scientific’s EPS estimate is -0.01.
How many shares outstanding does Milestone Scientific have?
Milestone Scientific has 77,892,080 shares outstanding.
What happened to Milestone Scientific’s price movement after its last earnings report?
Milestone Scientific reported an EPS of -$0.02 in its last earnings report, missing expectations of -$0.01. Following the earnings report the stock price went down -4.412%.
Which hedge fund is a major shareholder of Milestone Scientific?
Currently, no hedge funds are holding shares in MLSS
---
Milestone Scientific Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$3.00 (226.09% Upside)
$3.00 (226.09% Upside)
Insider Transactions
Sold Shares
Worth $15.4K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
46.03%
12-Months-Change
Fundamentals
Return on Equity
-63.82%
Trailing 12-Months
Asset Growth
5.59%
Trailing 12-Months
Company Description
Milestone Scientific
Milestone Scientific Inc. designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. The company also offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances; and disposable injection handpiece for the tactile control during the injection. In addition, it provides CompuFlo Epidural, a computer controlled anesthesia system for use in various medical applications. Further, the company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Livingston, New Jersey.
---
MLSS Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a generally positive outlook with significant revenue growth in the third quarter, strong gross margins, and strategic progress in the medical division with Medicare Part B alignment. However, concerns remain with the lack of revenue from China and an overall revenue decline over the nine-month period. Despite these challenges, the company seems well-positioned for future growth, particularly in international markets.Read More>---
MLSS Stock 12 Month Forecast
Average Price Target
$3.00
▲(226.09% Upside)
Technical Analysis
Best Analysts Covering MLSS
1 Year
1 Year Success Rate
7/19 ratings generated profit
1 Year Average Return
-12.72%
reiterated a buy rating 5 months ago
Copying Anthony Vendetti's trades and holding each position for 1 Year would result in 36.84% of your transactions generating a profit, with an average return of -12.72% per trade.
---